Role of Angiotensin and Its Inhibition in Hypertension, Ischemic Heart Disease, and Heart Failure
- 1 February 2001
- journal article
- case report
- Published by Wolters Kluwer Health in Hypertension
- Vol. 37 (2) , 342-345
- https://doi.org/10.1161/01.hyp.37.2.342
Abstract
This is a personal historical account relating the events that led to the first application of angiotensin inhibition (either by ACE inhibitors or by angiotensin receptor blockade) to the investigation of the pathogenesis and treatment of hypertension, ischemic heart disease, and heart failure. Included are animal experiments, clinical observations, and the earliest clinical experimental studies that helped define some of the detrimental effects of angiotensin II and the beneficial hemodynamic results of its inhibition, which have been subsequently corroborated and amplified by large randomized outcome trials.Keywords
This publication has 14 references indexed in Scilit:
- Renin-Angiotensin System Inhibition in Conscious Sodium-Depleted DogsJournal of Clinical Investigation, 1978
- Angiotensin II InhibitionJAMA, 1977
- Vasodilator Therapy of Cardiac FailureNew England Journal of Medicine, 1977
- Reciprocal Relation between Renin Dependency and Sodium Dependency in Essential HypertensionNew England Journal of Medicine, 1976
- Reciprocation of Renin Dependency with Sodium Volume Dependency in Renal HypertensionScience, 1975
- ANGIOTENSIN-II BLOCKADE IN MAN BY SAR1-ALA8-ANGIOTENSIN II FOR UNDERSTANDING AND TREATMENT OF HIGH BLOOD-PRESSUREThe Lancet, 1973
- Angiotensin-Sodium Interaction in Blood Pressure Maintenance of Renal Hypertensive and Normotensive RatsScience, 1973
- Essential Hypertension: Renin and Aldosterone, Heart Attack and StrokeNew England Journal of Medicine, 1972
- Hypertension of Renal Origin: Evidence for Two Different MechanismsScience, 1971
- ACUTE RENAL FAILURE, TUBULAR NECROSIS, AND MYOCARDIAL INFARCTION INDUCED IN THE RABBIT BY INTRAVENOUS ANGIOTENSIN IIThe Lancet, 1971